| Literature DB >> 22588497 |
Shigeyuki Asano1, Kikuo Mori, Kazuki Yamazaki, Tetsutaro Sata, Takayuki Kanno, Yuko Sato, Masaru Kojima, Hiromi Fujita, Yasushi Akaike, Haruki Wakasa.
Abstract
For tularemia, a zoonosis caused by the gram-negative coccobacillus Francisella tularensis, research of the relation between skin lesions and lymph node lesions has not been reported in the literature. This report describes skin lesions and lymph node lesions and their mutual relation over time for tularemia in Japan. Around the second day after infection (DAI), a subcutaneous abscess was observed (abscess form). Hand and finger skin ulcers formed during the second to the fourth week. Subcutaneous and dermal granulomas were observed with adjacent monocytoid B lymphocytes (MBLs) (abscess-granulomatous form). From the sixth week, large granulomas with central homogeneous lesions emerged diffusely (granulomatous form). On 2-14 DAI, F. tularensis antigen in skin lesions was detected in abscesses. During 7-12 DAI, abscesses with adjacent MBLs appeared without epithelioid granuloma (abscess form) in regional lymph nodes. During the second to fifth week, granulomas appeared with necrosis (abscess-granulomatous form). After the sixth week, large granulomas with a central homogeneous lesion (granulomatous form) appeared. F. tularensis antigen in lymph node lesions was observed in the abscess on 7-92 DAI. Apparently, F. tularensis penetrates the finger skin immediately after contact with infected hares. Subsequently, the primary lesion gradually transfers from skin to regional lymph nodes. The regional lymph node lesions induced by skin lesion are designated as dermatopathic lymphadenopathy. This study revealed temporal differences of onset among the skin and lymph node lesions.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22588497 PMCID: PMC3371331 DOI: 10.1007/s00428-012-1246-7
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064
Antibodies used in this immunohistochemical study
| Antibody | Clone | Specificity | Source | Clonality | Retrieval | Dilution |
|---|---|---|---|---|---|---|
| CD3 | 2GV6 | T cells | Roche | M | Mic | 1:1 |
| CD4 | 1 F6 | Helper/inducer T cells | Nichirei | M | Mic | 1:1 |
| CD5 | CD5/5456 | T cells | Dako | M | Mic | 1:100 |
| CD8 | C8/144B | Cytotoxic/suppressor T cells | Dako | M | Mic | 1:1 |
| CD10 | 56 C6 | CALLA, Immature B cells, germinal center B cells | Nichirei | M | Mic | 1:1 |
| CD20 | L26 | B cells | Dako | M | Mic | 1:1 |
| CD30 | Ber-H2 | Activated B cells | Dako | M | Mic | 1:100 |
| CD68 | KP1 | Macrophage, plasmacytoid T cells | Dako | M | Mic | 1:50 |
| CD83 | 1H4b | Dendritic cells, Langerhans cells | Novo | M | Mic | 1:20 |
| CD163 | 10D6 | Macrophage scavenger receptor | Lab | M | Mic | 1:50 |
| CD204 | Macrophage scavenger receptor | a | M | Mic | 1:1 | |
| Langerin | 12D6 | Langerhans cells | Novo | M | Mic | 1:100 |
| S-100 | Langerhans cells, melanocyte, Schwan cells | Dako | P | Non | 1:1 | |
| D2-40 | D2-40 | Lymph vessel | Nichirei | M | Mic | 1:1 |
| Fascin | 55 K-2 | Dendritic cells, interdigitating reticulum cells | Dako | M | Mic | 1:50 |
| HLA-DR | TAL.1B5 | Langerhans cells, Macrophages, B cells, activated T cells | Dako | M | Mic | 1:25 |
| IgG | IgG | Dako | P | Non | 1:1 | |
| IgA | IgA | Dako | P | Mic | 1:1 | |
| IgM | IgM | Dako | P | Mic | 1:1 | |
| κ | R10-21-f3 | κ | Dako | M | Non | 1:1 |
| λ | N10/2 | λ | Dako | M | Non | 1:1 |
|
|
| b | P | Auto | 1:1 |
Roche Roche Diagnostics, Arizona, USA, Nichirei Nichirei, Tokyo, Japan, Dako Dako, Ca, USA, Novo Novocastra, UK, Lab Lab Vision, USA
M monoclonal, P polyclonal, Mic microwave, Auto autoclave, Non non treated
aAnti-CD204 antibody and banti-F. tularensis antibody were supplied from Dr. Takeya and Dr. Hotta, respectively
Summary of clinical findings of skin lesions, 19 cases
| Age distribution | 19–69 | Mean 43 years, median 44 years |
| Male:female ratio | 4:1 | |
| Occupation | Farmer | 13 cases (68 %) |
| Charcoal maker | 2 | |
| Other | 4 | |
| Day after infection | 1–96 days | Mean 30 days, median 19 days |
| Site | Skin (hand finger) | 4 cases |
| Subcutaneous (axillary, elbow) | 14 | |
| Unknown | 1 |
Summary of clinical findings of lymphadenopathy, 54 cases
| Age distribution | 8–69 | Mean 39 years, median 37 years | |
| Male:female ratio | 4:1 | ||
| Occupation | Farmer | 40 cases (74 %) | |
| Charcoal maker | 3 | ||
| Carpenter | 2 | ||
| Other (teacher, woodcutter, charcoal maker, hotel worker) furrier, child) | 9 | ||
| Day after infection | 6–133 days | Mean 33 days, median 24 days | |
| Site | Axillary (76 %) | Left | 21 |
| Right | 21 | ||
| Bilateral | 4 | ||
| Elbow (7 %) | Left | 1 | |
| Right | 3 | ||
| Mandible | 1 | ||
| Unknown | 3 |
Fig. 1Skin and subcutaneous. a Central necrosis and abscess (asterisk) of subcutaneous area with marginal lymphocytes (4 DAI). b Immunostaining. F. tularensis antigens (arrow) were detected mainly in abscesses and necrotic areas (4 DAI) (anti-F. tularensis antibody). c Skin ulcer (arrow) of the right middle finger (14 DAI). d Various sizes of granulomas (arrow) at ulcer base of dermis. e Lymphocytes, apoptotic cells, and macrophages were observed within marked distended lymph vessels (arrow) (30 DAI). (Anti-D2-40 antibody). f Epithelioid granuloma (arrow) in dermis with central necrosis (asterisk) was adjacent to CD 20+ lymphocyte aggregation (bold arrow = italic). g Enlargement of f. Many CD 20+ lymphocytes (monocytoid B lymphocytes; MBLs) aggregated near the granuloma (19 DAI). h Large irregularly shaped epithelioid granuloma with central homogeneous lesion (asterisk) in dermis. No antigen was detected in the lesion (75 DAI)
Fig. 2Histology and F. tularensis antigen of skin and lymph node. F. tularensis antigen was detected during 2–14 DAI, and 7–92 DAI, in abscess and necrotic area of skin and lymph node, respectively. Day, days after infection (numbers of columns denote days); LN, lymph node; Antigen, antigen for F. tularensis; Histology was classified into three forms: abscess, abscess–granulomatous, and granulomatous [7]
Fig. 3Abscess form lymph node lesion (10 DAI). a Abscess and necrosis lesion (asterisk) without epithelioid granuloma located in the paracortex of a lymph node (10 DAI). b F. tularensis antigens (arrow) were mainly present in abscesses and necrosis lesions (asterisk) (10 DAI). (Anti-F. tularensis antibody). c Abscess–granulomatous form lymph node lesion (14 DAI). Marked swelled axillary lymph node on the cut section. d Central abscess and necrosis lesion (asterisk) was surrounded by thick epithelioid cell granuloma (14 DAI). e CD20+ monocytoid B lymphocytes (MBLs) aggregations (arrow) were adjacent to granuloma. Asterisk, abscess and necrosis lesion (14 DAI). f CD4/CD8 ratio was 2.3 ( A), 1.1 ( B), and 2.0 ( C) in abscess–granulomatous form of lymph node. g Granulomatous form lymph node lesion (92 DAI). Large irregular granuloma with central homogeneous lesion (asterisk). Very few antigens were detected in abscesses. h CD20+ cells (MBLs) aggregations (arrow) were adjacent to the outer layer of epithelioid cell granuloma. Asterisk, central homogeneous lesion